Arkolith/Insider Trading/FTH/Form 4

Parikh Anand Kiran

President and CEO, DirectorFaeth Therapeutics, Inc. (FTH) · full profile →Form 4 · filed Jun 24, 2026
Net Buying
Open-Market Buys
$55K
Open-Market Sells
$0
Net Open-Market Flow
$55K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Buy(P)3K$19.76$55K764K
Jun 22, 2026Option exercise(M)45K$1.16$52K809K
Jun 22, 2026Option exercise(M)8K$1.16$10K818K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 22, 2026Option exercise(M)45K—$092K
Jun 22, 2026Option exercise(M)8K—$04K

Transaction Codes

P
Open-market purchase
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002111813-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Faeth Therapeutics, Inc.

Build

Ask your agent about FTH insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002111813-26-000010"
Ask your agent
Use Arkolith to summarize insider buying and selling at Faeth Therapeutics, Inc.
over the last 90 days and cite the filings.